SCHEMBL20610784

SCHEMBL20610784

CCCCCC(O)CCC(O)C(O)CCCCCC=C(CC(O)CO)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.44
GPR84 Q9NQS5 5/20 0.43
FFAR4 Q5NUL3 2/20 0.42
FFAR1 O14842 2/20 0.42
EP300 Q09472 1/20 0.41
FAAH O00519 1/20 0.39
PTPN1 P18031 1/20 0.38
CYP2D6 P10635 2/20 0.37
DGKA P23743 1/20 0.37
SPHK1 Q9NYA1 1/20 0.37
GMNN O75496 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
THPO P40225 1/20 0.37
MTOR P42345 1/20 0.37
BLM P54132 1/20 0.37
KDM4E B2RXH2 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28621414 0.88 GRIK1 (0.54) GRIK1GPR84FFAR4FFAR1EP300
SCHEMBL27636120 0.88 GRIK1 (0.54) GRIK1GPR84FFAR4FFAR1EP300
SCHEMBL28626388 0.88 GRIK1 (0.54) GRIK1GPR84FFAR4FFAR1EP300
SCHEMBL28621418 0.88 GRIK1 (0.54) GRIK1GPR84FFAR4FFAR1EP300
SCHEMBL6942687 0.88 GRIK1 (0.54) GRIK1GPR84FFAR4FFAR1EP300
SCHEMBL5687634 0.76 GRIK1 (0.41) GRIK1GPR84FFAR4FFAR1EP300
SCHEMBL1506722 0.73 FFAR1 (0.52) GPR84FFAR4FFAR1FAAHPTPN1
SCHEMBL1506742 0.73 FFAR1 (0.52) GPR84FFAR4FFAR1FAAHPTPN1
SCHEMBL1506724 0.73 FFAR1 (0.52) GPR84FFAR4FFAR1FAAHPTPN1
SCHEMBL1506743 0.73 FFAR1 (0.52) GPR84FFAR4FFAR1FAAHPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11555021-B2 Fatty acid derivatives and their use THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-01-17 US disclosed
US-20220274940-A1 FATTY ACID DERIVATIVES AND THEIR USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN (US) 2022-09-01 US disclosed
US-20210139440-A1 FATTY ACID DERIVATIVES AND THEIR USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC (US) 2021-05-13 US disclosed
EP-3649115-A1 FATTY ACID DERIVATIVES AND THEIR USE The U.S.A. as represented by the Secretary, Department of Health and Human Services (US) 2020-05-13 EP disclosed
WO-2019010414-A1 FATTY ACID DERIVATIVES AND THEIR USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2019-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139440-A1 FATTY ACID DERIVATIVES AND THEIR USE FFAR3, FFAR1, FFAR2 GRIK1 326/4885GPR84 125/4885FFAR4 4/4885
US-20220274940-A1 FATTY ACID DERIVATIVES AND THEIR USE FFAR3, FFAR1, FFAR2 GRIK1 326/4885GPR84 125/4885FFAR4 4/4885
US-11555021-B2 Fatty acid derivatives and their use FFAR3, FFAR1, FFAR2 GRIK1 326/4885GPR84 125/4885FFAR4 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.